Cat.#: ACPP-1673
Despition | TIMM8A Human Recombinant |
SIZE | 5 µg |
Purity | > 90.0% (SDS-PAGE) |
Form | Sterile Filtered colorless solution. |
Storage | Store at 4°C for 2-4 weeks. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
ACPP-1048 | Recombinant Human Butyrylcholinesterase Protein (6×His Tag) (AC1048) | 50 µg | inquiry |
ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
ACPP-1139 | Recombinant Human Cadherin 10 Protein (6×His Tag) (AC1139) | 50 µg | inquiry |
ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg | inquiry |
ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
ACPP-1007 | Recombinant Human Secretogranin 3 Protein (6×His Tag) (AC1007) | 50 µg | inquiry |
ACPP-1309 | CCR5 Blocking Peptide (AC1309) | 250 µg | inquiry |
ACPP-1557 | Human TARDBP Protein (AC1557) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.